Impact of an oral gonadotropin‐releasing hormone antagonist on severe ovarian hyperstimulation syndrome in a patient with breast cancer who received a sustained‐release gonadotropin‐releasing hormone agonist: A case report-Reference-Cited by-同舟云学术

Impact of an oral gonadotropin‐releasing hormone antagonist on severe ovarian hyperstimulation syndrome in a patient with breast cancer who received a sustained‐release gonadotropin‐releasing hormone agonist: A case report

Published:2021-10-12 Issue:12 Volume:47 Page:4472-4477
ISSN:1341-8076
Container-title:Journal of Obstetrics and Gynaecology Research
language:en
Short-container-title:J. Obstet. Gynaecol. Res.

Author:

Hanada Tetsuro¹^ORCID,Kimura Fuminori¹^ORCID,Kitazawa Jun¹,Morimune Aina¹,Murakami Takashi¹

Affiliation:

1. Department of Obstetrics and Gynecology Shiga University of Medical Science Otsu Japan

Publisher

Wiley

Subject

Obstetrics and Gynaecology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jog.15059

Reference15 articles.

1. Ovarian reserve after treatment with alkylating agents during childhood

2. Fertility preservation in young women with early‐stage breast cancer;Vuković P;Acta Clin Croat,2019

3. Motherhood after breast cancer: can we balance fertility preservation and cancer treatment? A narrative review of the literature;Carneiro MM;JBRA Assist Reprod,2018

4. Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

5. A modern classification of OHSS

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of ovarian hyperstimulation syndrome in women with malignancies undergoing treatment with long-acting gonadotropin-releasing hormone agonist after controlled ovarian hyperstimulation for fertility preservation: a systematic review;Therapeutic Advances in Reproductive Health;2023-01

2. Leuprorelin/menotropin/tamoxifen;Reactions Weekly;2022-02